Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Bausch Lomb

Bausch & Lomb CEO: the AI hysteria is nothing new

AI is being talked about as though business has never encountered a technological shift before. And just like the other times, one thing gets overlooked.

Bausch + Lomb CEO: Standing still is the new falling behind

Bausch + Lomb CEO: Standing still is the new falling behind

At Bausch & Lomb, foundational AI learning is now mandatory. If employees don’t complete it, they’re not eligible for their bonus.

Activist Investor Seeks Strategic Overhaul At Contact Lens Maker Cooper, Suggests Merger With Bausch + Lomb

Activist Investor Seeks Strategic Overhaul At Contact Lens Maker Cooper, Suggests Merger With Bausch + Lomb

Activist investor Jana Partners has reportedly taken a stake in The Cooper Companies (NASDAQ:COO) and is pressing the medical-device maker to evaluate strategic alternatives — including a potential merger between its contact-lens division and Bausch + Lomb (NYSE:BLCO).

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

This Bausch Health Companies Unusually Active Option Is a No-Brainer

Bausch Health Companies had the 8th-highest Vol/OI ratio in Wednesday trading. The pharmaceutical company’s unusual options activity suggests it might have more gains ahead.

Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022

Expert Ratings for Bausch & Lomb

Over the past 3 months, 7 analysts have published their opinion on Bausch & Lomb (NYSE:BLCO) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022

Scoop Up These 4 Buy-Rated Healthcare Stocks Trading Near 52-Week Lows

Scoop Up These 4 Buy-Rated Healthcare Stocks Trading Near 52-Week Lows

Despite the prevailing bearish investor sentiment, the healthcare industry is expected to continue growing amid an increase in global chronic diseases, rapid medical advancements, and an aging population. The stocks of quality healthcare companies Bausch Health (BHC), Teleflex (TFX), Abcam (ABCM), and Integra LifeSciences (IART) are currently trading near their…

1

Organisations

the Wall Street Journal

American Express

B of A Securities

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play